U.S. pharma huge copyright scrapped two experimental weight loss drugs last yr—a at the time-each day tablet, lotiglipron, because of elevated liver enzymes in addition to a twice-day by day pill, danuglipron, on account of potent side effects—but CEO Albert Bourla has said the compa